semaglutide with low bmi 2.4 mg clinical outcomes in patients obesity or overweight in a real‐world setting: A 6‐month retrospective study in the United States (SCOPE) Is Semaglutide (Wegovy) Approved For

This means it treats obesity by keeping you fuller for longer and reducing your appetite , so you can eat fewer calories without constantly feeling hungry

Practical scenarios: when alternating might make sense Despite the limitations, there are specific situations where alternating between semaglutide and tirzepatide could be a reasonable approach

Who should consider alternatives Given the emerging safety data, several groups should particularly consider switching to a B12-free tirzepatide formulation with separate B12 supplementation

GLP-1 medical weight loss is a wonderful tool for getting you where youd like to be